---
document_datetime: 2025-01-13 15:56:00
document_pages: 16
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/olanzapine-viatris-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: olanzapine-viatris-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 9.101305
conversion_datetime: 2025-12-21 19:04:19.412493
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Olanzapine Viatris

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                           | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|-------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| T/0061               | Transfer of Marketing Authorisation                                                             | 29/11/2024                          | 19/12/2024                                  | SmPC, Labelling and PL           |           |
| IG/1772              | A.2.a - Administrative change - Change in the (invented) name of the medicinal product for CAPs | 15/10/2024                          | 09/12/2024                                  | SmPC, Labelling and PL           |           |

1  Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions are issued for all other procedures.

2  A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures.

3  SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet).

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| IAIN/0059   | B.III.1.a.1 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - New certificate from an already approved manufacturer                                                | 08/08/2024   | n/a        |                        |
|-------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|------------------------|
| N/0058      | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                       | 08/05/2024   | 09/12/2024 | PL                     |
| IB/0057     | B.II.d.1.z - Change in the specification parameters and/or limits of the finished product - Other variation                                                                                                                            | 19/05/2023   | 20/06/2024 | SmPC and PL            |
| N/0056      | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                       | 12/01/2023   | 20/06/2024 | PL                     |
| IAIN/0055   | B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing | 22/11/2021   | 28/11/2022 | Annex II and PL        |
| T/0054      | Transfer of Marketing Authorisation                                                                                                                                                                                                    | 15/09/2021   | 12/11/2021 | SmPC, Labelling and PL |
| IB/0053     | B.II.d.1.c - Change in the specification parameters and/or limits of the finished product - Addition of a new specification parameter to the specification with its corresponding test method                                          | 06/07/2021   | n/a        |                        |
| IA/0052     | A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                          | 05/03/2021   | 12/11/2021 | Annex II and PL        |

<div style=\"page-break-after: always\"></div>

| IB/0051   | - Submission of a new/updated or of Ph. Eur. Certificate of Suitability to the Ph. Eur. Monograph - Updated certificate an already approved manufacturer                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | 17/09/2020   | n/a        |                                  | B.III.1.a.2 deletion relevant from   |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|----------------------------------|--------------------------------------|
| IA/0050/G | This was an application for a group of variations. B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer | 31/07/2020   | n/a        |                                  |                                      |
| IB/0049   | C.I.3.z - Change(s) in the SPC, Labelling or PL intended to implement the outcome of a procedure concerning PSUR or PASS or the outcome of the assessment done under A 45/46 - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | 02/06/2020   | 28/08/2020 | SmPC, Annex II, Labelling and PL |                                      |

<div style=\"page-break-after: always\"></div>

|           | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by         | 31/07/2019   | 28/08/2020   | SmPC and PL            | IB/0048 the MAH   |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|------------------------|-------------------|
| N/0047    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                             | 07/03/2019   | 28/08/2020   | PL                     |                   |
| IA/0046   | B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure                                                                                                                                                 | 14/11/2018   | n/a          |                        |                   |
| T/0045    | Transfer of Marketing Authorisation                                                                                                                                                                                                                          | 19/09/2018   | 12/11/2018   | SmPC, Labelling and PL |                   |
| IA/0044   | B.II.e.1.a.1 - Change in immediate packaging of the finished product - Qualitative and quantitative composition - Solid pharmaceutical forms                                                                                                                 | 13/07/2018   | 12/11/2018   | SmPC, Labelling and PL |                   |
| IB/0043   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH | 12/12/2017   | 12/11/2018   | SmPC and PL            |                   |
| IAIN/0042 | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                               | 07/02/2017   | 25/07/2017   | SmPC, Labelling and PL |                   |

<div style=\"page-break-after: always\"></div>

| IA/0041   | A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release)                                                             | 12/12/2016   | n/a        |                        |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|------------------------|
| IB/0040   | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                               | 21/07/2016   | 25/07/2017 | SmPC, Labelling and PL |
| IG/0647   | C.I.8.a - Introduction of or changes to a summary of Pharmacovigilance system - Changes in QPPV (including contact details) and/or changes in the PSMF location                                                                                              | 11/01/2016   | n/a        |                        |
| IB/0038   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH | 02/07/2015   | 06/07/2016 | SmPC, Labelling and PL |
| IAIN/0037 | B.III.1.a.1 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - New certificate from an already approved manufacturer                                                                      | 16/03/2015   | n/a        |                        |
| IA/0036   | A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release)                                                             | 13/10/2014   | n/a        |                        |
| IB/0034/G | This was an application for a group of variations.                                                                                                                                                                                                           | 31/10/2013   | 19/08/2014 | SmPC,                  |

<div style=\"page-break-after: always\"></div>

|         | B.II.e.5.a.2 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change outside the range of the currently approved pack sizes B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes B.II.e.5.a.2 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change outside the range of the currently approved pack sizes   |            |            | Labelling and PL   |                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|--------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IA/0035 | A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | 24/10/2013 | n/a        |                    |                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| IB/0033 | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data are submitted by the MAH                                                                                                                                                                                                                                                                                                                                                               | 19/08/2013 | 19/08/2014 | SmPC and PL        |                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| R/0032  | Renewal of the marketing authorisation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | 21/03/2013 | 22/05/2013 | Annex II           | Based on the CHMP review of the available information and on the basis of a re-evaluation of the benefit risk balance, the CHMP was of the opinion that the quality, safety and efficacy of this medicinal product continues to be adequately and sufficiently demonstrated and therefore considered that the benefit risk profile of Olanzapine Mylan continues to be favourable. The CHMP was of the opinion that the renewal could be |

<div style=\"page-break-after: always\"></div>

|           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |            |            |                                  | granted with unlimited validity.   |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|------------------------------------|
| IA/0031   | A.5.b - Administrative change - Change in the name and/or address of a manufacturer of the finished product, including quality control sites (excluding manufacturer for batch release)                                                                                                                                                                                                                                                                                                                                                          | 27/09/2012 | n/a        |                                  |                                    |
| IB/0030   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data are submitted by the MAH                                                                                                                                                                                                                                                                                                   | 26/09/2012 | 25/10/2012 | SmPC, Annex II, Labelling and PL |                                    |
| IB/0029/G | This was an application for a group of variations. C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data are submitted by the MAH C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data are submitted by the MAH | 18/01/2012 | 03/08/2012 | SmPC and PL                      |                                    |
| IB/0028   | To add a new unit dose pack size of 100x1 tablets for the 7.5mg film-coated tablets (EU/1/08/475/057). B.II.e.5.a.2 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change outside                                                                                                                                                                                                                                                                                      | 12/10/2011 | 12/10/2011 | SmPC, Labelling and PL           |                                    |

<div style=\"page-break-after: always\"></div>

|           | range of the currently approved pack sizes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |            |            |                                  | the   |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|-------|
| IA/0027/G | This was an application for a group of variations. B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site B.II.b.1.b - Replacement or addition of a manufacturing site for the FP - Primary packaging site B.II.b.2.a - Change to batch release arrangements and quality control testing of the FP - Replacement or addition of a site where batch control/testing takes place B.II.b.2.b.1 - Change to batch release arrangements and quality control testing of the FP - Not including batch control/testing B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes | 12/10/2011 | 12/10/2011 | SmPC, Annex II, Labelling and PL |       |

<div style=\"page-break-after: always\"></div>

| product - Change in tablets, ampoules, etc.) the range of the currently B.II.e.5.a.1 - Change product - Change in tablets, ampoules, etc.) the range of the currently B.II.e.5.a.1 - Change product - Change in tablets, ampoules, etc.) the range of the currently B.II.e.5.a.1 - Change product - Change in tablets, ampoules, etc.) the range of the currently B.II.e.5.a.1 - Change product - Change in tablets, ampoules, etc.) the range of the currently B.II.e.5.a.1 - Change product - Change in tablets, ampoules, etc.) the range of the currently B.II.e.5.a.1 - Change product - Change in tablets, ampoules, etc.) the range of the currently B.II.e.5.a.1 - Change product - Change in tablets, ampoules, etc.) the range of the currently   |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

<div style=\"page-break-after: always\"></div>

|           | tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes   |            |     |                        | product - Change   |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|------------------------|--------------------|
| IB/0023   | B.I.d.1.z - Stability of AS - Change in the re-test period/storage period or storage conditions - Other variation                                                                                                                                                                                                                                                                                                                                                                                         | 04/08/2011 | n/a |                        |                    |
| IB/0020   | B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale (supported by real time data)                                                                                                                                                                                                                                                                                                                                                                 | 06/07/2011 | n/a | SmPC, Labelling and PL |                    |
| IB/0022/G | This was an application for a group of variations. B.I.a.2.e - Changes in the manufacturing process of the AS - Minor change to the restricted part of an ASMF B.I.b.1.h - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Addition or replacement (excl. Biol. or immunol. substance) of a specification parameter as a result of a safety or quality issue B.I.c.2.b - Change in the specification parameters                                   | 05/07/2011 | n/a |                        |                    |

<div style=\"page-break-after: always\"></div>

<!-- image -->

|           | limits of the immediate packaging of the AS - of a new specification parameter to the specification with its corresponding test method - Administrative change - Change in the name address of a manufacturer or supplier of the starting material, reagent or intermediate used the manufacture of the AS                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |            |            |                                  | and/or Addition A.4 and/or AS, in   |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|-------------------------------------|
| IB/0021/G | This was an application for a group of variations. B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes B.II.e.5.a.2 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change outside the range of the currently approved pack sizes B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes Change in pack size of the finished | 01/07/2011 | 01/07/2011 | SmPC, Annex II, Labelling and PL | B.II.e.5.a.1 - product - Change     |

<div style=\"page-break-after: always\"></div>

|           | tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes B.II.e.5.a.2 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change outside the range of the currently approved pack sizes B.II.e.5.a.2 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change outside the range of the currently approved pack sizes B.II.e.5.a.2 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change outside the range of the currently approved pack sizes B.II.e.5.a.2 - Change in pack size of the finished product - Change in the number of units (e.g.   |            |     |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| IA/0024/G | This was an application for a group of variations. B.I.b.1.b - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Tightening of                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | 16/06/2011 | n/a |

<div style=\"page-break-after: always\"></div>

|           | specification limits B.I.b.1.c - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Addition of a new specification parameter to the specification with its corresponding test method B.I.b.1.c - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Addition of a new specification parameter to the specification with its corresponding test method B.I.b.1.c - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Addition of a new specification parameter to the specification with its corresponding test method B.I.b.1.c - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Addition of a new specification parameter to the specification with its corresponding test method B.I.b.1.c - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Addition of a new specification parameter to the specification with its   |            |     |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| IA/0019/G | This was an application for a group of variations. A.7 - Administrative change - Deletion of manufacturing sites B.II.b.1.a - Replacement or addition of a                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | 05/01/2011 | n/a |

<div style=\"page-break-after: always\"></div>

|         | the FP - Secondary packaging site B.II.b.1.b - Replacement or addition of a manufacturing site for the FP - Primary packaging site B.II.b.2.a - Change to batch release arrangements and quality control testing of the FP - Replacement or addition of a site where batch control/testing takes place   |            |     |             | manufacturing site for   |
|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-------------|--------------------------|
| IB/0018 | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data are submitted by the MAH                                                           | 15/11/2010 | n/a | SmPC        |                          |
| IB/0017 | B.II.b.5.z - Change to in-process tests or limits applied during the manufacture of the finished product - Other variation                                                                                                                                                                               | 20/07/2010 | n/a |             |                          |
| IB/0016 | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data are submitted by the MAH                                                           | 22/03/2010 | n/a | SmPC and PL |                          |
| IB/0004 | IB_33_Minor change in the manufacture of the finished product                                                                                                                                                                                                                                            | 22/01/2010 | n/a |             |                          |
| IB/0003 | IA_09_Deletion of manufacturing site IB_07_c_Replacement/add. of manufacturing site: All other manufacturing operations ex. batch release                                                                                                                                                                | 22/01/2010 | n/a |             |                          |

<div style=\"page-break-after: always\"></div>

| IA/0015   | IA_09_Deletion of manufacturing site                                                                                                                                                                   | 18/12/2009   | n/a        | Annex II and PL   |                                                                                                                                                                                 |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|-------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IA/0014   | IA_09_Deletion of manufacturing site                                                                                                                                                                   | 18/12/2009   | n/a        | Annex II and PL   |                                                                                                                                                                                 |
| IA/0013   | IA_09_Deletion of manufacturing site                                                                                                                                                                   | 18/12/2009   | n/a        | Annex II and PL   |                                                                                                                                                                                 |
| IA/0012   | IA_09_Deletion of manufacturing site                                                                                                                                                                   | 18/12/2009   | n/a        | Annex II and PL   |                                                                                                                                                                                 |
| IA/0011   | IA_09_Deletion of manufacturing site                                                                                                                                                                   | 18/12/2009   | n/a        |                   |                                                                                                                                                                                 |
| IA/0010   | IA_09_Deletion of manufacturing site                                                                                                                                                                   | 18/12/2009   | n/a        |                   |                                                                                                                                                                                 |
| IA/0009   | IA_09_Deletion of manufacturing site                                                                                                                                                                   | 18/12/2009   | n/a        |                   |                                                                                                                                                                                 |
| IA/0008   | IA_09_Deletion of manufacturing site                                                                                                                                                                   | 18/12/2009   | n/a        |                   |                                                                                                                                                                                 |
| IA/0007   | IA_07_a_Replacement/add. of manufacturing site: Secondary packaging site                                                                                                                               | 18/12/2009   | n/a        |                   |                                                                                                                                                                                 |
| IA/0006   | IA_05_Change in the name and/or address of a manufacturer of the finished product                                                                                                                      | 18/12/2009   | n/a        | Annex II and PL   |                                                                                                                                                                                 |
| IA/0005   | IA_07_a_Replacement/add. of manufacturing site: Secondary packaging site                                                                                                                               | 18/12/2009   | n/a        |                   |                                                                                                                                                                                 |
| II/0002   | Update to section 4.8 of the Summary of Product Characteristics (SPC) in line with the Product Information of the reference medicinal product. An editorial change was made in section 4.4 of the SPC. | 24/09/2009   | 23/10/2009 | SmPC and PL       | The SPC was updated to align it with that of the reference medicinal product. This followed a change to the SPC of the reference medicinal product via the following procedure: |

<div style=\"page-break-after: always\"></div>

|         | In addition, the Marketing Authorisation Holder took the opportunity to update the contact details for the local representative in Slovakia in the Package Leaflet and to introduce minor linguistic changes in the Bulgarian, Danish, Dutch, French, German, Greek, Hungarian, Italian, Latvian, Lithuanian, Polish, Portuguese, Romanian and Swedish Annexes. Update of Summary of Product Characteristics and Package Leaflet   |            |            |      | Zyprexa (EMEA/H/C/000115/II/0099).                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| II/0001 | Update to sections 4.4 and 4.9 of the Summary of Product Characteristics (SPC) in line with the Product Information of the reference product Zyprexa. Update of Summary of Product Characteristics                                                                                                                                                                                                                                 | 25/06/2009 | 17/07/2009 | SmPC | Following changes to the SPC of the reference medicinal product Zyprexa, sections 4.4 and 4.9 of the Olanzapine Mylan SPC were updated. Recommendations on monitoring of patients for signs and symptoms of hyperglycaemia, worsening of glucose control and weight gain were added to section 4.4 and new information on acute overdose was added to section 4.9. The summary of the above mentioned changes may be found in the EPARs (module 8B) of Zyprexa (II/96) and Zyprexa Velotab (II/68). |